Cell and Gene Logistics
-
Bringing CGTs To Middle Income, Developing Countries
4/25/2024
In this segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, panelists take an optimistic look at the future promise of bringing CGTs to patients.
-
Intermediate Storage For Cell Therapies
4/25/2024
This segment from the Cell & Gene Live digital event explores intermediate storage options for cell therapy products and the factors to consider when working with these vendors.
-
The Importance Of Mock Runs, Testing Your Processes
4/25/2024
Panelists in this Cell & Gene Live digital event discuss the importance of performing mock runs to pressure test your processes and operations before sending out a commercial product.
-
Selecting The Right Vendors When Building Your Supply Chain
4/25/2024
What factors should you consider when looking for supply chain vendors?
-
The Challenges With Shipping Cell Therapy Products
4/25/2024
In this Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site segment, panelists share some of the worst-case shipping scenarios they’ve encountered when transporting cellular products.
-
The Need For Improved Cryoprotectants
4/25/2024
Cryoprotectants are added chemicals or media that protect cells during freezing and thawing — and until we can lyophilize cells, they’re our best bet at preserving cell therapies for storage.
-
Long-Term Cryopreservation And Storage Of Stem Cells
4/25/2024
How long can you store frozen stem cells? Receive expert advice on the long-term storage and cryopreservation of stem cells and stem-cell derived therapies.
-
Site Storage And The Last Mile
4/25/2024
In this segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, panelists discuss bringing stem-cell derived therapies to patients.
-
The Importance Of Cryopreservation
4/25/2024
In this segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, our panelists talk about the challenges with freezing and thawing stem-cell derived therapies.
-
Mitigating Human Error In The Cell Therapy Supply Chain
4/24/2024
There are a lot of moving parts involved in bringing stem-cell derived therapies to patients, and thus, many points where things can go south.